50 likes | 62 Views
Global pulmonary drug delivery devices market was valued at approximately US$ 35,000 Mn in 2017; which is anticipated to reach a value of nearly US$ 46,000 Mn by 2026, expanding at a CAGR of about 3.0% from 2018 to 2026.
E N D
©2019 Transparency Market Research, All Rights Reserved Pulmonary Drug Delivery Devices Market Product - Dry Powder Inhalers, Metered Dose Inhalers, Nebulizers; Application - Asthma, COPD, Cystic Fibrosis; Distribution Channel - Retail Pharmacies, Hospital Pharmacies, E-commerce Forecast 2018 - 2026 ©2019 Transparency Market Research, All Rights Reserved
©2019 Transparency Market Research, All Rights Reserved Table of Content Sr. No. Content Chapter 1 Preface Chapter 2 Assumptions and Research Methodology Chapter 3 Executive Summary: Global Pulmonary Drug Delivery Devices Market Chapter 4 Market Overview Chapter 5 Key Insights Chapter 6 Global Pulmonary Drug Delivery Devices Market Analysis and Forecast, by Product Chapter 7 Global Pulmonary Drug Delivery Devices Market Analysis and Forecast, by Application Global Pulmonary Drug Delivery Devices Market Analysis and Forecast, by Distribution Channel Chapter 8 Chapter 9 Global Pulmonary Drug Delivery Devices Market Analysis and Forecast, by Region Chapter 10 North America Pulmonary Drug Delivery Devices Market Analysis and Forecast Chapter 11 Europe Pulmonary Drug Delivery Devices Market Analysis and Forecast Chapter 12 Asia Pacific Pulmonary Drug Delivery Devices Market Analysis and Forecast Chapter 13 Latin America Pulmonary Drug Delivery Devices Market Analysis and Forecast Chapter 14 Middle East & Africa Pulmonary Drug Delivery Devices Market Analysis and Forecast Chapter 15 Competition Landscape
©2019 Transparency Market Research, All Rights Reserved Pulmonary Drug Delivery Devices Market: Snapshot • Increase in the prevalence and incidence of respiratory diseases across globe, increasing population of smokers across countries, rising prescription of the combination therapies, and rising research & development in the asthma & COPD treatment. • Technological advancements, innovative product offerings, rising merger & acquisitions, and increasing geriatric population, and increase in access to health care are projected to drive the global pulmonary drug delivery devices market. • global pulmonary drug delivery devices market has been dry powder inhaler, metered dose inhaler, and nebulizers ©2019 Transparency Market Research, All Rights Reserved
©2019 Transparency Market Research, All Rights Reserved Reports Highlights • Global pulmonary drug delivery devices market was valued at approximately US$ 35,000 Mn in 2017; which is anticipated to reach a value of nearly US$ 46,000 Mn by 2026, expanding at a CAGR of about 3.0% from 2018 to 2026. • Key Players – • Boehringer Ingelheim GmbH, Novartis AG, GlaxoSmithKline plc, AstraZeneca plc, Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., MannKind Corporation ©2019 Transparency Market Research, All Rights Reserved Request Sample
©2019 Transparency Market Research, All Rights Reserved To know more about us, please visit our website: www.transparencymarketresearch.com For sales queries or new topics email us on: sales@transparencymarketresearch.com For other queries contact: 90 State Street, Albany NY – 12207, United States Tel: +1-518-618-1030 T H A N K Y O U